Sign-in to Ask A Doctor - 24x7
OR
Sign in with GoogleGet your health question answered instantly from our pool of 18000+ doctors from over 80 specialties
How Can Systemic Sclerosis Be Treated?
Hi! My mother is suffering from systemic sclerosis and have been undergoing treatment from the last two years. Very lately, she got dark brown patches near both her armpit. Is it something to worry about? An year before she had get similar patches on her legs.
Mon, 16 Oct 2017
Dear as you described the lesions may be your mother suffering from
Superficial morphoea - It is typically seen as symmetrical mauve-coloured patches, usually in skin folds of the groin, armpits or under breasts. This type is most commonly found in middle-aged women.
Superficial morphoea part of localised scleroderma.
Medical Care
Lesions of superficial circumscribed morphea often undergo gradual spontaneous resolution over a 3- to 5-year period. Limited disease can often be managed with topical therapy or lesion-limited phototherapy.
Treatment of active lesions with superpotent topical or intralesional corticosteroids may help reduce inflammation and prevent progression, although there is a lack of data supporting their efficacy.
Tacrolimus 0.1% ointment applied twice daily for 12 weeks may be a useful first-line agent for active, limited plaque morphea, as supported by a small double-blind, placebo-controlled study.
Superficial morphoea - It is typically seen as symmetrical mauve-coloured patches, usually in skin folds of the groin, armpits or under breasts. This type is most commonly found in middle-aged women.
Superficial morphoea part of localised scleroderma.
Medical Care
Lesions of superficial circumscribed morphea often undergo gradual spontaneous resolution over a 3- to 5-year period. Limited disease can often be managed with topical therapy or lesion-limited phototherapy.
Treatment of active lesions with superpotent topical or intralesional corticosteroids may help reduce inflammation and prevent progression, although there is a lack of data supporting their efficacy.
Tacrolimus 0.1% ointment applied twice daily for 12 weeks may be a useful first-line agent for active, limited plaque morphea, as supported by a small double-blind, placebo-controlled study.
I find this answer helpful
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
Related questions you may be interested in
Loading Online Doctors....